Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Vertex Pharmaceuticals Incorporated”

980 pharma patents match "Vertex Pharmaceuticals Incorporated" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 980
Index total 30,257
Page 26 / 41

Quick answer

This filtered view shows 980 pharmaceutical patents matching "Vertex Pharmaceuticals Incorporated" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

980 results for “Vertex Pharmaceuticals Incorporated” · 30,257 patents in full index Clear search

  1. US 8124781

    Processes for producing cycloalkylcarboxamido-pyridine benzoic acids

    Vertex Pharmaceuticals Incorporated · Granted Feb 28, 2012 · Expires Feb 23, 2032

    granted

  2. US 8119631

    Inhibitors of interleukin-1β converting enzyme

    Vertex Pharmaceuticals Incorporated · Granted Feb 21, 2012 · Expires Feb 16, 2032

    granted

  3. US 8101770

    Pyridones useful as inhibitors of kinases

    Vertex Pharmaceuticals Incorporated · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted

  4. US 8101767

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted

  5. US 8097636

    Heterocyclic derivatives as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Jan 17, 2012 · Expires Jan 12, 2032

    granted

  6. US 8093392

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Jan 10, 2012 · Expires Jan 5, 2032

    granted

  7. US 8076357

    Compositions of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Vertex Pharmaceuticals Incorporated · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted

  8. US 8076343

    Benzimidazoles useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted

  9. US 8071618

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted

  10. US 8067606

    Gyrase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted

  11. US 8067417

    Imidazo[1,2-F]pteridines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted

  12. US 8058271

    Selective inhibitors of rock protein kinase and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted

  13. US 8039475

    Co-crystals and pharmaceutical compositions comprising the same

    Vertex Pharmaceuticals Incorporated · Granted Oct 18, 2011 · Expires Oct 13, 2031

    granted

  14. US 8039661

    Thiophene-carboxamides useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Oct 18, 2011 · Expires Oct 13, 2031

    granted

  15. US 8039623

    Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

    Vertex Pharmaceuticals Incorporated · Granted Oct 18, 2011 · Expires Oct 13, 2031

    granted

  16. US 8039491

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Oct 18, 2011 · Expires Oct 13, 2031

    granted

  17. US 8034950

    Processes for the facile synthesis of diaryl amines and analogues thereof

    Vertex Pharmaceuticals Incorporated · Granted Oct 11, 2011 · Expires Oct 6, 2031

    granted

  18. US 8034832

    Gyrase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Oct 11, 2011 · Expires Oct 6, 2031

    granted

  19. US 8022202

    Dihydrodiazepines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Sep 20, 2011 · Expires Sep 15, 2031

    granted

  20. US 8022041

    Prodrug of an ICE inhibitor

    Vertex Pharmaceuticals Incorporated · Granted Sep 20, 2011 · Expires Sep 15, 2031

    granted

  21. US 8017619

    Compositions useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Sep 13, 2011 · Expires Sep 8, 2031

    granted

  22. US 8017781

    Azaindazoles useful as inhibitors of kinases

    Vertex Pharmaceuticals Incorporated · Granted Sep 13, 2011 · Expires Sep 8, 2031

    granted

  23. US 8012999

    Modulators of CFTR

    Vertex Pharmaceuticals Incorporated · Granted Sep 6, 2011 · Expires Sep 1, 2031

    granted

  24. US 8003660

    Modulators of muscarinic receptors

    Vertex Pharmaceuticals Incorporated · Granted Aug 23, 2011 · Expires Aug 18, 2031

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.